Zobrazeno 1 - 10
of 148
pro vyhledávání: '"NK Ibrahim"'
Autor:
NK Ibrahim, S Schreek, B Cinar, L Loxha, J-P Bourquin, B Bornhauser, M Forster, M Stanulla, A Gutierrez, L Hinze
Publikováno v:
Klinische Pädiatrie.
Autor:
NK Ibrahim, S-C Tang, AJ Brenner, S Kesari, DE Piccioni, CK Anders, JA Carillo, P Chalasani, P Kabos, S Puhalla, AA Garcia, KH Tkaczuk, MS Ahluwalia, NJ Lakhani, P Kumthekar
Publikováno v:
Cancer Research. 77:P1-12
Background: The incidence of CNS metastatic disease in breast cancer patients (pts) seems to have increased in recent years with the improvement of systemic therapy. However, treatment options for CNS metastases have remained limited due to the inabi
Publikováno v:
Egyptian Journal of Biochemistry and Molecular Biology; Vol 29, No 1 (2011)
Resveratrol, a natural phytoalexin, has demonstrated a wide variety of biological activities, which make it a good candidate for treatment of diabetes mellitus. The present study was aimed to evaluate the properties of resveratrol (RSV) as an antidia
Autor:
Yam C; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patel M; The University of Texas MD Anderson Cancer Center, United States., Hill HA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sun R; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bassett RL; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kong E; The University of Texas MD Anderson Cancer Center, United States., Damodaran S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Koenig KB; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Abouharb S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Saleem S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bisen AK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Murthy RK; University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ramirez DL; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Rauch GM; The University of Texas MD Anderson Cancer Center, Houston, United States., Adrada BE; The University of Texas MD Anderson Cancer Center, Houston, United States., Candelaria RP; The University of Texas MD Anderson Cancer Center, Houston, United States., Wang X; The University of Hawaii Cancer Center, Honolulu, HI, United States., Mittendorf EA; Brigham and Women's Hospital, Boston, MA, United States., Thompson AM; Baylor College of Medicine, Houston, United States., White JB; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Ravenberg EE; Eli Lilly and Company, Indianapolis, United States., Clayborn AR; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ding QQ; M.D.Anderson Cancer Cancer Center, Houston, TX, United States., Booser DJ; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Oke O; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Brewster AM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hortobagyi GN; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ibrahim NK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Litton JK; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Valero V; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Arun BK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Chang JT; University of Texas Health Science Center at Houston, Houston, TX, United States., Chen K; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Korkut A; University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Moulder SL; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Huo L; MD Anderson Cancer Center, The University of Texas, Houston, Texas, United States., Lim B; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Ueno NT; The University of Texas MD Anderson Cancer Center, Houston, Hawaii, United States.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.
Autor:
Raghavendra AS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Oct; Vol. 20 (10), pp. 1348-1359. Date of Electronic Publication: 2024 May 15.
Autor:
Akkoc Mustafayev FN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Liu DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Texas, USA., Gutierrez AM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Lewis JE; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Booser DJ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Koenig K; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Yu D; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Sneige N; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA., Arun BK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA.
Publikováno v:
European journal of breast health [Eur J Breast Health] 2023 Oct 01; Vol. 19 (4), pp. 267-273. Date of Electronic Publication: 2023 Oct 01 (Print Publication: 2023).
Autor:
Loxha L; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Ibrahim NK; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Stasche AS; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Cinar B; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Dolgner T; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Niessen J; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Schreek S; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Fehlhaber B; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Forster M; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany., Stanulla M; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Hinze L; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 26; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 26.
Autor:
Nelson BE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Saleem S; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Damodaran S; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Somaiah N; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Piha-Paul S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Moore JA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz B; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ogbonna D; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Karp DD; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dumbrava E; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodon Ahnert J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zheng X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Booser DJ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bhosale P; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rojas Hernandez CM; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2023 Jul 15; Vol. 129 (14), pp. 2201-2213. Date of Electronic Publication: 2023 Apr 04.
Autor:
Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Guenther K; Immatics Biotechnologies GmbH, Tuebingen, Germany., Andersson BS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mendrzyk R; Immatics Biotechnologies GmbH, Tuebingen, Germany., Alpert A; Immatics US, Inc., Houston, Texas., Wagner C; Immatics Biotechnologies GmbH, Tuebingen, Germany., Nowak A; Immatics Biotechnologies GmbH, Tuebingen, Germany., Aslan K; Immatics Biotechnologies GmbH, Tuebingen, Germany., Satelli A; Immatics US, Inc., Houston, Texas., Richter F; Immatics Biotechnologies GmbH, Tuebingen, Germany., Kuttruff-Coqui S; Immatics Biotechnologies GmbH, Tuebingen, Germany., Schoor O; Immatics Biotechnologies GmbH, Tuebingen, Germany., Fritsche J; Immatics Biotechnologies GmbH, Tuebingen, Germany., Coughlin Z; Immatics US, Inc., Houston, Texas., Mohamed AS; Immatics US, Inc., Houston, Texas., Sieger K; Immatics US, Inc., Houston, Texas., Norris B; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ort R; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Beck J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vo HH; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hoffgaard F; Immatics Biotechnologies GmbH, Tuebingen, Germany., Ruh M; Immatics Biotechnologies GmbH, Tuebingen, Germany., Backert L; Immatics Biotechnologies GmbH, Tuebingen, Germany., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fuhrmann D; Immatics Biotechnologies GmbH, Tuebingen, Germany., Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas., Kee BK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas., Halperin DM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas., Nogueras-Gonzalez GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vining D; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Singh H; Immatics N.V., Tuebingen, Germany., Reinhardt C; Immatics N.V., Tuebingen, Germany., Britten CM; Immatics N.V., Tuebingen, Germany., Hilf N; Immatics Biotechnologies GmbH, Tuebingen, Germany., Weinschenk T; Immatics N.V., Tuebingen, Germany., Maurer D; Immatics Biotechnologies GmbH, Tuebingen, Germany., Walter S; Immatics US, Inc., Houston, Texas.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Jul 05; Vol. 11 (7), pp. 925-945.
Autor:
Shaaban NZ; Biochemistry Department, Faculty of Science, Alexandria University, P.O. Box 21568, Alexandria, Egypt., Ibrahim NK; Radiation Biology Department, National Center for Radiation Research & Technology, Egyptian Atomic-Energy Authority, P.O. Box 8029, Cairo, Egypt., Saada HN; Radiation Biology Department, National Center for Radiation Research & Technology, Egyptian Atomic-Energy Authority, P.O. Box 8029, Cairo, Egypt., El-Rashidy FH; Biochemistry Department, Faculty of Science, Alexandria University, P.O. Box 21568, Alexandria, Egypt., Shaaban HM; National Cancer Institute, Cairo University, P.O. Box 11796, Cairo, Egypt., Elbakary NM; Radiation Biology Department, National Center for Radiation Research & Technology, Egyptian Atomic-Energy Authority, P.O. Box 8029, Cairo, Egypt., Kodous AS; Biochemistry Department, Faculty of Science, Alexandria University, P.O. Box 21568, Alexandria, Egypt.; Radiation Biology Department, National Center for Radiation Research & Technology, Egyptian Atomic-Energy Authority, P.O. Box 8029, Cairo, Egypt.
Publikováno v:
Oncology research [Oncol Res] 2023 Feb 09; Vol. 30 (6), pp. 269-276. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2022).